Brief: Moberg Pharma Q1 EBITDA SEK -1.5 Million
12/05/2026 07:00
May 12 (Reuters) - Moberg Pharma Q1 net income SEK -1.3 million. Q1 EBIT SEK -1.9 million Q1 EPS SEK -0.03
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains